In Vitro Activity of Doripenem in Combination with Various Antimicrobials Against Multidrug-Resistant Acinetobacter baumannii: Possible Options for the Treatment of Complicated Infection

Pharmacodynamics of the Antibacterial Effect of and Emergence of Resistance to Doripenem in Pseudomonas aeruginosa and Acinetobacter baumannii in anIn VitroPharmacokinetic Model

(2012) Karen E. Bowker et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Comparative in vitro activity of carbapenems against major Gram-negative pathogens: results of Asia-Pacific surveillance from the COMPACT II study

(2012) Pattarachai Kiratisin et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

Colistin resistance of Acinetobacter baumannii: clinical reports, mechanisms and antimicrobial strategies

(2012) Y. Cai et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Emergence of resistance to carbapenems in Acinetobacter baumannii in Europe: clinical impact and therapeutic options

(2011) Marie Kempf et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

Acinetobacter infection - an emerging threat to human health

(2011) Paolo Visca et al.   IUBMB LIFE

Activity of doripenem with and without levofloxacin, amikacin, and colistin against Pseudomonas aeruginosa and Acinetobacter baumannii

(2010) Glenn A. Pankuch et al.   DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE

Synergistic activities between carbapenems and other antimicrobial agents against Acinetobacter baumannii including multidrug-resistant and extensively drug-resistant isolates

(2010) Pattarachai Kiratisin et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

Changing carbapenemase gene pattern in an epidemic multidrug-resistant Acinetobacter baumannii lineage causing multiple outbreaks in central Italy

(2010) Silvia D'Arezzo et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Epidemic multidrug-resistant Acinetobacter baumannii related to European clonal types I and II in Rome (Italy)

(2009) S. D'Arezzo et al.   CLINICAL MICROBIOLOGY AND INFECTION

A review of tigecycline — the first glycylcycline

(2009) Lance R. Peterson   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

Tigecycline in combination with other antimicrobials: a review of in vitro, animal and case report studies

(2009) J.M. Entenza et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

Global spread of carbapenem-resistant Acinetobacter baumannii

(2009) P. G. Higgins et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

In vitro activity of tigecycline in combination with various antimicrobials against multidrug resistant Acinetobacter baumannii

(2009) Luigi Principe et al.   Annals of Clinical Microbiology and Antimicrobials

Whole-Genome Pyrosequencing of an Epidemic Multidrug-Resistant Acinetobacter baumannii Strain Belonging to the European Clone II Group

(2008) M. Iacono et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Pandrug Resistance (PDR), Extensive Drug Resistance (XDR), and Multidrug Resistance (MDR) among Gram‐Negative Bacilli: Need for International Harmonization in Terminology

(2008) Matthew E. Falagas et al.   CLINICAL INFECTIOUS DISEASES

Colistin monotherapy vs. combination therapy: evidence from microbiological, animal and clinical studies

(2008) N. Petrosillo et al.   CLINICAL MICROBIOLOGY AND INFECTION

In vitro activity of doripenem against Acinetobacter baumannii clinical isolates

(2008) Sara Marti et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

In vitro activity of tigecycline against multidrug-resistant Acinetobacter baumannii

(2008) A. Capone et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY